Breaking News
Healthcare
Market News
The Market Buzz
Breaking News: Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (OTCQB: BTHCF) (CSE: BTH) is pleased to announce that it has been accepted to present its pre-clinical data on its inflammatory bowel...